Does the MDS-UPDRS provide the precision to assess progression in early Parkinson ’s disease? Learnings from the Parkinson’s progression marker initiative cohort

ConclusionsThe MDS-UPDRS-II and -III have psychometric limitations which limits the precision of measurement of motor symptoms and impact in early PD. This can lead to insensitivity in detecting differences and clinical change. Importantly, the diagnostic psychometric evidence provided by the RMT analysis provides a clear starting point for how to improve the quantification of clinically relevant concepts to characterize the course of early PD.
Source: Journal of Neurology - Category: Neurology Source Type: research